BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18697201)

  • 1. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway.
    Zhou Y; Zeng Z; Zhang W; Xiong W; Wu M; Tan Y; Yi W; Xiao L; Li X; Huang C; Cao L; Tang K; Li X; Shen S; Li G
    Int J Cancer; 2008 Nov; 123(9):2065-72. PubMed ID: 18697201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.
    Deng M; Zhang W; Tang H; Ye Q; Liao Q; Zhou Y; Wu M; Xiong W; Zheng Y; Guo X; Qin Z; He W; Zhou M; Xiang J; Li X; Ma J; Li G
    Oncogene; 2013 Sep; 32(36):4273-83. PubMed ID: 23069661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
    Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
    PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of increased Id-1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells.
    Wang X; Xu K; Ling MT; Wong YC; Feng HC; Nicholls J; Tsao SW
    Mol Carcinog; 2002 Sep; 35(1):42-9. PubMed ID: 12203366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma.
    Zhang W; Fan S; Zou G; Shi L; Zeng Z; Ma J; Zhou Y; Li X; Zhang X; Li X; Tan M; Xiong W; Li G
    Tumour Biol; 2015 Feb; 36(2):675-83. PubMed ID: 25286756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
    Deng M; Ye Q; Qin Z; Zheng Y; He W; Tang H; Zhou Y; Xiong W; Zhou M; Li X; Yan Q; Ma J; Li G
    Tumour Biol; 2013 Jun; 34(3):1793-800. PubMed ID: 23479198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines.
    Zhang H; Feng X; Liu W; Jiang X; Shan W; Huang C; Yi H; Zhu B; Zhou W; Wang L; Liu C; Zhang L; Jia W; Huang W; Li G; Shi J; Wanggou S; Yao K; Ren C
    J Cell Biochem; 2011 Jul; 112(7):1832-43. PubMed ID: 21400573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP.
    Yu G; Zhang T; Jing Y; Bao Q; Tang Q; Zhang Y
    Life Sci; 2017 Apr; 175():47-51. PubMed ID: 28315691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.
    Yi HM; Li H; Peng D; Zhang HJ; Wang L; Zhao M; Yao KT; Ren CP
    Oncol Res; 2006; 16(6):261-72. PubMed ID: 17476971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression, genetic and epigenetic alterations of LTF gene in nasopharyngeal carcinoma cell lines].
    Yi HM; Li YC; Zhong RH
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):729-33. PubMed ID: 21163060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.
    Niu Z; Liu H; Zhou M; Wang H; Liu Y; Li X; Xiong W; Ma J; Li X; Li G
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):183-91. PubMed ID: 25630654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
    Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
    Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy.
    Ruan L; Wang GL; Yi H; Chen Y; Tang CE; Zhang PF; Li MY; Li C; Peng F; Li JL; Chen ZC; Xiao ZQ
    J Cell Biochem; 2010 Jul; 110(4):975-81. PubMed ID: 20564197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes.
    Zhou Y; Wang W; Zheng D; Peng S; Xiong W; Ma J; Zeng Z; Wu M; Zhou M; Xiang J; Xiang B; Li X; Li X; Li G
    Med Oncol; 2012 Sep; 29(3):1456-62. PubMed ID: 22011934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Momordica Charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo.
    Fang EF; Zhang CZ; Ng TB; Wong JH; Pan WL; Ye XJ; Chan YS; Fong WP
    Cancer Prev Res (Phila); 2012 Jan; 5(1):109-21. PubMed ID: 21933914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.